Clinical Lung Cancer · 2018 · 41 citations · 16 references
MedicineOncologyPharmacologyChemotherapyMedical OncologyMolecular OncologyCancer ProgressionLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsMetabolic Reprogramming In CancerTargeted Cancer TherapyLung AdenocarcinomaLung Cancer Chemoprevention
16
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.6K citations · Full text
Medicine, Oncology, Pharmacology +16
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4.1K citations
Medicine, Oncology, Pharmacology +10
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
Tony Mok, Yi‐Long Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2016 · 3.3K citations · Full text
Medicine, Oncology, Pharmacology +16
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding, Gad Getz, David A. Wheeler et al. · Nature · 2008 · 2.7K citations · Full text